相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway
Yuan Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca2+/Calcineurin/p-NFATc3 Pathway
Xin Wang et al.
JOURNAL OF HEALTHCARE ENGINEERING (2021)
Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis
Shuangquan Lin et al.
BIOENGINEERED (2021)
Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats
Akira Sugiyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways
Jintao Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7
Jing-Si Wang et al.
BIOENGINEERED (2020)
Osteopontin attenuates inflammation via JAK2/STATI pathway in hyperglycemic rats after intracerebral hemorrhage
Lei Gong et al.
NEUROPHARMACOLOGY (2018)
Longitudinal Real-World Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece (vol 4, 213, 2017)
Argyrios Tzouvelekis et al.
FRONTIERS IN MEDICINE (2018)
Role of spironolactone in the treatment of heart failure with preserved ejection fraction
Constantine E. Kosmas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis
Chunmei Li et al.
SCIENTIFIC REPORTS (2017)
Is Inhibition of Hypertrophy a Good Therapeutic Strategy in Ventricular Pressure Overload?
Gabriele G. Schiattarella et al.
CIRCULATION (2015)
Inhibition of JNK Phosphorylation by a Novel Curcumin Analog Prevents High Glucose-Induced Inflammation and Apoptosis in Cardiomyocytes and the Development of Diabetic Cardiomyopathy
Yong Pan et al.
DIABETES (2014)
Cardiovascular remodelling in coronary artery disease and heart failure
Gerd Heusch et al.
LANCET (2014)
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Jana S. Burchfield et al.
CIRCULATION (2013)
Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms
Ioannis Anestopoulos et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1
Beatriz Martin-Fernandez et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Reduction of Rat Cardiac Hypertrophy by Osthol is Related to Regulation of Cardiac Oxidative Stress and Lipid Metabolism
Feng Zhou et al.
LIPIDS (2012)
Cardioprotective effects of hydrogen sulfide
Gabor Szabo et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2011)
Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats
Yiqun Tang et al.
PHYTOMEDICINE (2011)
Hydrogen Sulfide and Oxygen Sensing in the Cardiovascular System
Kenneth R. Olson et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Long-term survival of cancer patients compared to heart failure and stroke: A systematic review
Vasileios Askoxylakis et al.
BMC CANCER (2010)
Differential Regulation of Proteasome Function in Isoproterenol-Induced Cardiac Hypertrophy
Oliver Drews et al.
CIRCULATION RESEARCH (2010)
Effects of Pirfenidone on Proliferation, Migration, and Collagen Contraction of Human Tenon's Fibroblasts In Vitro
Xianchai Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Thromboembolism and toxic shock syndrome: A case presentation and literature update
UM Musharrafieh et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2004)
分享论文
